A treatment with defined indications
Topical minoxidil may be used for certain forms of androgenetic alopecia. Indications vary by product and concentration. Sudden, patchy or unexplained hair loss needs assessment before treatment is started. A scalp product should not be applied to the beard or eyebrows without medical advice.
Choosing a suitable formulation
Dr Donabella may favour oral minoxidil when appropriate, particularly when topical applications are difficult to sustain. Ease of use may support adherence; it does not make the formulation suitable for everyone. The decision depends on factors including medical history and tolerability.
Tolerability and precautions
Oral minoxidil was originally used to treat high blood pressure. Increased body hair can occur; low blood pressure, palpitations and fluid retention are also considerations. Cardiovascular history and other medication must be reviewed. Unusual symptoms require medical advice.
Distinguishing formulations
Topical and oral formulations are not interchangeable. Oral prescribing for hair loss may be off-label depending on the country and product, requiring appropriate information and monitoring. This article does not provide an individual dose or treatment protocol.
Recent scientific publications
Selected references consulted on 18 November 2026. Studies concern specific populations and protocols; they do not predict individual outcomes.
International expert consensus
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern hair loss in hair transplant patients using a modified Delphi process
Gupta AK et al. Expert Opinion on Pharmacotherapy, 2026. · PMID 41782304
Recommendations on assessment, monitoring and minoxidil around hair transplantation. This is a consensus rather than a comparative trial; treatment and timing remain individual.
Cross-sectional adherence study
Comparing Adherence, Side Effects, and Satisfaction in Oral and Topical Minoxidil: A Cross-Sectional Study
Kobayashi S et al. Journal of Drugs in Dermatology, February 2025. · PMID 39913220
Surveyed oral minoxidil users reported easier use, fewer missed days and fewer discontinuations due to application difficulties. This small observational survey informs adherence; it does not establish overall efficacy or safety superiority of oral treatment.